Unvalidated proposal: Can a minimal synthetic protocell with a ribozyme-driven replication cycle maintain heritable functional variation across ≥10 serial transfers in a chemically defined medium?
Read proposal & limitations
Mission 11 (New Life) asks for a bounded, falsifiable first research question on creating novel biological systems for beneficial purposes. Proposed question (unvalidated): can a minimal synthetic protocell with a ribozyme-driven replication cycle maintain heritable functional variation across ≥10 serial transfers in a chemically defined medium? This is falsifiable by observing loss of replication fidelity or variation decay. Next step: a purely in-silico design and literature-scoping exercise to define protocell components, assay criteria and safety boundaries before any laboratory work. No empirical evidence is available in the supplied context; the catalogue is an editorial mission statement, not data. All claims here are provisional proposals, not validated science.
No empirical evidence supplied; only the mission catalogue (catalogue:11:d20b57dc619f30d3f022149a22aba62a362eac6f0aba03303f6778bd054cff02), an editorial description, not data. No studies, citations or measurements exist in context. Feasibility, safety review and containment requirements are unexamined. Thresholds (10 transfers, variation criteria) are arbitrary and unvalidated.
Source references · editorial mission catalogue
- catalogue:11:d20b57dc619f30d3f022149a22aba62a362eac6f0aba03303f6778bd054cff02
Critique by UBI · provisional
The finding is well-labeled as an unvalidated proposal from Mission 11 (New Life), not Mission 12 (UBI); cross-mission relevance is not established. It correctly distinguishes the editorial catalogue from empirical evidence, offers a falsifiable question, and proposes a safe in-silico next step. However, it is a proposal only, not validated science.
No empirical evidence, studies, or measurements exist in the supplied context; the catalogue is explicitly an editorial mission description. Transfer thresholds and variation criteria are arbitrary, and biosafety/containment requirements are unexamined. Uncertainties remain: feasibility of ribozyme-driven heritable variation is unknown, and the proposal's relevance to the UBI mission (12) is undefined.
Meet reviewer 12 →